We present two cases of cryptococcal meningitis in people subsequently diagnosed with idiopathic CD4+ lymphopenia. Both presented with new onset headaches without sinister features and were sent home on multiple occasions from emergency departments. Cryptococcal meningitis in HIV-negative patients poses major diagnostic and management problems; the associated mortality is 9%-27%. We suggest performing blood and cerebrospinal fluid cryptococcal antigen tests in all people with lymphocytic meningitis.
cAse 1
A 33-year-old Irish woman presented to the emergency department with headaches without red flag features and was discharged. She re-presented several weeks later with vomiting and was again discharged. Five weeks after onset, she presented for a third time. She had a history of juvenile idiopathic arthritis in remission without treatment. Neurological examination was unremarkable and she was apyrexial. Initial investigations included a raised serum C reactive protein of 68 mg/L (normal <5) and a low lymphocyte count 0.2×10 9 /L (1.1-4.0). On cerebrospinal fluid (CSF) examination, the opening pressure was 28 cmH 2 O, lymphocyte count 14×10 6 /L, protein 0.83 g/L and glucose 1.9 mmol/L (plasma 4.4 mmol/L). Cryptococcus neoformans was grown from her blood culture and subsequently from the CSF. The cryptococcal antigen was also positive in blood at 1:160 and CSF at 1:1280.
HIV serology was negative, but immunological investigations showed a CD4+ lymphopenia with cell count 10×10 6 /L (500-1500×10 6 /L). There was also a mild CD8+ lymphopenia that resolved on repeat testing. She had normal serum immunoglobulins and IgG subclasses, except for a mildly elevated serum IgA. A serological screen for other viral causes of lymphopenia was negative. The antinuclear antibody titre was 1:1280 and nuclear ribonucleoprotein antibody was positive, raising the possibility of subclinical mixed connective tissue disease. MR scan of brain (T2-weighted images) showed small patches of non-specific hyperintensity within the cerebral white matter, associated with mildly enlarged perivascular spaces and, after contrast, small focal enhancing lesions within the right internal capsule and left caudate nucleus (figure 1).
She was an inpatient for 6 weeks and received intravenous amphotericin B and flucytosine, had three lumbar punctures for CSF pressure monitoring (table 1) and made a full recovery. She has remained well for 12 months on maintenance treatment with oral fluconazole and prophylactic co-trimoxazole. Her CD4+ lymphocyte counts have remained below 50×10 6 /L.
cAse 2
A 48-year-old man of Pakistani descent developed headaches and photophobia after a cataract operation and was discharged from three different emergency departments over a 2-week period. He was finally admitted after appearing profoundly confused at a routine outpatient appointment. On transfer to the emergency department, he required sedation and intubation due to agitation and to enable further assessment. He had abused cocaine and heroin until 4 years earlier A difficult cAse and had received treatment for tuberculosis 2 years previously after developing night sweats and cervical lymphadenopathy; a lymph node biopsy had shown granulomata without necrosis or acid-fast bacilli, and culture was negative. An initial CT scan of head showed right maxillary antral mucosal thickening only. Cerebrospinal fluid examination showed an opening pressure of 44 cmH 2 O, white cell count 212×10 6 /L (75% lymphocytes), protein 0.89 g/L, glucose 1.1 mmol/L and no growth after prolonged incubation. HIV serology was negative. We started intravenous aciclovir and ceftriaxone and subsequently added antituberculous therapy. An MR scan of brain showed gyral-sulcal restricted diffusion, in keeping with meningoencephalitis. Repeat lumbar puncture showed a positive CSF cryptococcal antigen and growth of C. neoformans.
He was treated on the intensive care unit with intravenous amphotericin B and flucytosine for 4 weeks. During this time, he had a persistently raised CSF pressure despite lumbar puncture. Further imaging showed communicating hydrocephalus and so he had a temporary lumbar drain insertion. Examination identified cervical and axillary lymphadenopathy and a repeat lymph node biopsy showed granulomatous inflammation with encapsulated yeasts, in keeping with disseminated cryptococcal infection. A repeat MR scan of brain showed patchy areas of abnormal signal bilaterally, related to the frontal, parietal, temporal and insular cortices (figure 2) but without meningeal enhancement. Immunological investigations subsequently showed a CD4+ lymphopenia. The CD56+ cell count was also mildly reduced and the CD19+ count was increased. His lymphocyte subsets were as follows:
6 /L (35%) and CD56 absolute 80×10 6 /L (5%). Serum immunoglobulins and IgG subclasses were normal.
He gradually improved during his 6-month admission but still has major cognitive problems. He remains distractible and impulsive, cannot comply with formal cognitive testing and can follow simple commands but needs prompting to eat or wash. He still takes maintenance oral fluconazole and prophylactic co-trimoxazole.
Discussion
The diagnosis was delayed in both cases, and this probably contributed to the adverse outcomes in the second case. Clinicians need increased awareness of cryptococcal infection in HIV-negative patients who have no overt immunocompromise.
Cryptococcal disease without HIV infection is rare, and most commonly occurs with organ transplants, haematological malignancies, renal or liver failure and chronic corticosteroid use. In the last 15 years, there has been a increasing recognition of a group of patients with previously unknown primary immunological disturbances that predispose to cryptococcal infection. These include people with idiopathic CD4+ lymphopaenia, antibodies against granulocyte-macrophage colony-stimulating factor or IFN-γ and monogenic disorders such as chronic granulomatous disease, hyperimmunoglobulin E syndromes and hyperimmunoglobulin IgM syndromes.
1 Idiopathic CD4+ lymphopaenia, first described in 1992, is defined by a CD4+ count below 300×10 6 /L on at least two occasions in the absence of HIV infection or other known immunodeficiency or treatment associated with A difficult cAse lymphopenia. 2 The cause remains unclear but may relate to defects in T-cell receptor signalling, including CXCR4 expression and UNC119 gene mutations. 1 Around 25% of patients have autoimmunity, most frequently systemic lupus erythematous. 3 These 'pseudo' immunocompetent patients present major diagnostic problems. Zonios et al reviewed all 53 cases of cryptococcal meningitis with idiopathic CD4+ lymphopenia in the literature to 2007. 4 The median age was 41 years with CD4+ count 82×10 6 /L (7-292×10 6 /L) at presentation. Only 42% had fever and only 4% had other opportunistic infections suggesting immunodeficiency. 4 The absence of fever caused significant diagnostic delay, as with our cases. Cryptococcal meningitis may be caused by C. neoformans, as in the cases described, or Cryptococcus gattii. C. neoformans occurs worldwide, with infections typically occurring in immunocompromised individuals. C. gattii, endemic in tropical and subtropical regions, has recently emerged in the Pacific northwest of North America and causes infection in seemingly immunocompetent individuals. 1 The investigation of HIV-negative cryptococcal meningitis is usually straightforward, but only if the diagnosis is considered. CSF white cell count and protein are higher, and CSF glucose is lower than in patients with HIV. 5 Cryptococcal antigen tests are positive in the CSF of 97% and serum of 87% of all patients with cryptococcal meningitis. The sensitivity in serum may be lower in HIV-negative people and was 77% in a cohort of solid organ transplant recipients. 6 False negatives with the latex agglutination assay may occur in patients with high antibody titres, due to the prozone effect, and in infection with C. gattii. A recently developed lateral flow assay is a point-of-care antigen test with an improved sensitivity in blood and CSF, including for C. gattii, and is not subject to the prozone effect.
7 MR brain scan findings are non-specific and include dilated Virchow-Robin spaces, pseudocysts, cryptococcomas and lacunar or cortical infarcts. Large cryptococommas are associated with C. gattii.
1 Clinicians should also consider immunological investigations after diagnosing cryptococcal infection in an HIV-negative patient.
The 2010 guidelines from the Infectious Disease Society of America cover treatment protocols derived from limited trials in HIV-positive patients. 8 HIV-positive patients are usually treated with amphotericin and flucytosine for at least 2 weeks. Liposomal amphotericin is preferred in HIV-negative patients because it is equally effective but better tolerated as treatment duration is 4-6 weeks. 1 Intravenous fluids, electrolyte replacement and a reduced dose of flucytosine may be needed in acute kidney injury to avoid bone marrow toxicity. Consolidation involves high-dose oral fluconazole for 8 weeks followed by maintenance therapy with lower doses usually for at least 6-12 months. 1 There is no clear evidence base to guide the duration of maintenance therapy, or secondary prophylaxis, in HIV-negative patients. Extrapolating from guidelines for HIV-infected patients, we recommend monitoring the CD4+ count and having a low threshold for continuing maintenance fluconazole (assuming no attributable side effects) and considering co-trimoxazole prophylaxis, if the CD4+ count remains below 100×10 6 /L. 8 The CSF pressure is raised in 19% of HIV-negative patients (median 23 cmH 2 0), 9 as in both of these cases. The raised pressure results from impaired CSF reabsorption with subsequent communicating hydrocephalus. Managing the raised CSF pressure involves regular therapeutic lumbar punctures until the pressure is below 25 cmH 2 O. 1 Occasionally, a lumbar drain is needed, as in case 2. Obstructive hydrocephalus can also develop in HIV-negative patients, particularly in those with large cryptococcomas secondary to C. gattii infection, and this may need ventricular shunting. Pappas et al reported that 11% of HIV-negative patients with cryptococcal meningitis required a permanent ventricular shunt. 9 Corticosteroids are not routinely recommended but may have a role in treating large cryptococommas associated with oedema or in immunocompetent patients who develop a postinfectious inflammatory response syndrome. 8 The mortality in cryptococcal meningitis is higher in HIV-negative patients; Pappas et al in 2013 reported that it was 27%. 5 However, in the aforementioned series of patients with idiopathic CD4+ lymphopaenia alone, it was only 9%. The reasons for these large differences in the two major series are unexplained, and we have no more recent mortality data in idiopathic CD4+ lymphopenia. Haematological malignancy, organ failure, absence of headache, male sex, altered mental status and possibly raised intracranial pressure are associated with increased mortality in HIV-negative patients. 1 conclusion HIV-negative patients with cryptococcal meningitis pose diagnostic and management problems because they may have no prior history suggesting immunosuppression; if there is a primary immunodeficiency,
Key points
► Cryptococcal meningitis rarely occurs in apparently immunocompetent patients. ► There are multiple non-HIV immunodeficiency syndromes, of which idiopathic CD4+ lymphopenia is the best known. ► Half of cases have no fever. ► Diagnostic delay is common and may contribute to mortality rates of 9%-27%. ► We recommend cryptococcal antigen testing in blood and CSF in all cases of lymphocytic meningitis.
A difficult cAse immune reconstruction may be impossible. The high mortality in HIV-negative patients necessitates a low index of suspicion in patients with a new onset of headaches. We advocate blood and CSF cryptococcal antigen testing in all cases of lymphocytic meningitis.
